MG
SANA icon

Marex Group’s Sana Biotechnology SANA Stock Holding History

Marex Group’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.9M Sell
3,989,100
-10,000
-0.3% -$32.2K 0.06% 163
2026
Q1 		$11.5M Buy
3,999,100
+266,320
+7% +$1.05M 0.07% 158
2025
Q4 		$15.2M Sell
3,732,780
-90,000
-2% -$403K 0.1% 136
2025
Q3 		$13.6M Buy
3,822,780
+5,000
+0.1% +$18.1K 0.1% 126
2025
Q2 		$10.4M Buy
3,817,780
+3,757,780
+6,263% +$7.75M 0.09% 133
2025
Q1 		$101K Buy
+60,000
New +$168K ﹤0.01% 620

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Marex Group's SANA Position: Q2 2026 in Review

Marex Group reduced its Sana Biotechnology (SANA) stake by 0.25% in Q2 2026, selling an estimated $32.2K and leaving 3,989,100 shares worth $13.9M. The position accounts for 0.06% of the portfolio, ranked #163.

Marex Group first reported a position in SANA in Q1 2025 and has held it in 6 quarters since. The position peaked at $15.2M in Q4 2025. 210 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Marex Group held 3,989,100 shares of Sana Biotechnology worth $13.9M as of Q2 2026.
  • Marex Group sold 10,000 Sana Biotechnology shares in Q2 2026, an estimated $32.2K.
  • Sana Biotechnology made up 0.06% of Marex Group's portfolio in Q2 2026, its #163 holding.
  • Marex Group first reported a position in Sana Biotechnology in Q1 2025 and has held it in 6 quarters since.
  • Marex Group's Sana Biotechnology position peaked at $15.2M in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.